Skip to main content

New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for one medicine.

Meropenem/vaborbactam (Vaborem®) was recommended for the treatment of serious bacterial infections in adults: specifically infections associated with carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC).

AWTTC’s Patient Access to Medicines Service (PAMS) supports the AWMSG to assess and monitor new medicines in Wales.